AUG 18, 2026 · PHASE 2 TRIAL
A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC
ClinicalTrials.gov
This is a clinical trial registry record describing a planned or active Phase 2 single-arm study with no results posted; it documents design and enrollment only.
Reported
Planned enrollment72
PhasePhase 2
Primary endpointICR-assessed ORR per RECIST 1.1